Copeia’s digital healthcare solutions evolve personalised cannabis treatment
switch to English
At Copeia, we develop digital healthcare solutions to optimise cannabis-based therapy. We support both patients and the healthcare industry — doctors, pharmacies, pharma, and health insurers — to drive improvements in personalised treatment that result in better health outcomes.
We believe that the future of healthcare lies in radical collaboration that transcends boundaries. Copeia empowers all who envision a smarter, more interconnected approach to evolve personal health.
Data-based solutions to accompany cannabis therapy.
-
Cannabis Product Database - Supporting a transparent cannabis therapy
For patients and physicians
-
Simplifying the prescription and reimbursement of medical cannabis
For patients and physicians
-
Efficient dosing and individual titration plans for focused care
Copeia Dosis EQ for physicians (DocCheck Login)
-
Physicians Experience Platform (PEP) Share knowledge, improve therapy
PEP by Copeia for physicians (DocCheck Login)
Copeia's innovative solutions simplify time-consuming processes and support patient-focused therapy
-
Support patient-focused therapy and help quickly and easily answer key questions regarding the prescription of cannabis medications
-
Facilitate the application process for patients and their treating physicians to obtain insurance coverage for medical cannabis therapy
-
Assist in creating individualized dosage plans, simplifying time-consuming processes, and providing pharmacological security for more flexibility in personalized therapy
-
Provide a transparent overview of available cannabis medications and easy access to laboratory analyses of individual batches and products
-
Support researchers and companies in collecting real-world data on the course of therapy with cannabis medications
-
With PEP by Copeia, we offer medical professionals simple and free access to a platform that visually presents medical experiences through structured case studies
Cannabis product database
Copeia supports a more transparent cannabis therapy
With a plant-based product like cannabis, fluctuations in the concentrations of active ingredients naturally occur. However, neither medical professionals nor patients usually have the ability to view the exact compositions. Copeia enables those affected to request an analysis certificate using the batch number on their product—for greater safety and transparency in cannabis therapy.
IIn partnership with pharmacies, we offer a Copeia QR code system. By simply scanning it with their phone, patients can obtain more detailed information about their specific product.
Application for reimbursement of cannabis therapy costs
Indication-specific, personalised, and free for patients
An effective solution to support applications for insurance coverage of cannabis medication therapy.
The application provides a dynamic questionnaire to support indication-specific cannabis therapies and assists in completing and justifying an application.
With detailed explanations, the application supports the application process and provides practical information for starting cannabinoid therapy.
In addition to an overview of individual cannabis medications, the application offers a dosage assistant for calculating the prescribed amount.
The Copeia CAM application provides a pre-selection of scientific literature and a research tool for finding current scientific publications on cannabis.
You can conveniently save and print your completed application as a PDF or export it as a Word document.
For patients and healthcare professionals.
Copeia Dosis EQ
Efficient dosing and individual titration plans for focused care
Efficient Dosing for Focused Care: This application allows for an intuitive creation of individual titration plans and prescription templates for cannabis extracts and dronabinol.
The Copeia Dose EQ provides a user-friendly and intuitive interface for creating individual titration plans, prescription templates, and detailed instructions for use.
The application features a clear representation of key parameters, offering significant advantages in the often complex dose calculation during initial prescription or therapy adjustments.
Through these functions, the application not only supports pharmacological safety but also enables targeted consideration of individual needs in prescribing for patients.
Sharing knowledge, improving therapy: From physicians, for physicians
The Physicians Experience Platform (PEP) aims to enhance personalized therapy with cannabis medications.
PEP provides medical professionals with easy and free access to a platform that visually presents medical experiences through structured case studies.
By capturing information on the treatment of individual symptoms, specific cannabis medications, additional medication, as well as dosages and side effects, PEP offers a structured approach to assessing individual medical cannabis therapy.
Entering case studies: PEP simplifies the documentation of clinical cases that provide insights into the treatment with cannabis medications. Case entry is done through an interactive form divided into nine sections. Clearly structured sections and meaningful selection options facilitate data entry.
Searching and Comparing Case Studies: PEP allows for the comparison of clinical aspects and treatment outcomes of individual case studies. Access to an extensive database enables the visualization of experiences from healthcare professionals. These real-world experiences systematically provide practical information.
PEP by Copeia
Copeia Publications
-
![]()
Der Schmerz: Patient-reported outcomes“ bei chronischen Erkrankungen unter Therapie mit Cannabisarzneimitteln
-
![]()
Literature Review of Challenges in Titration of Cannabis Extracts
-
![]()
Dosierung von Cannabisarzneimitteln bei oraler Applikation
-
![]()
Systematic Review of Clinical Pharmacokinetics of THC Following Consumption of Different Cannabis Products
-
![]()
The Picture of Medical Cannabis in Germany Painted by Patients‘ Words and Sex Differences
-
![]()
Unsafe Medical Abbreviations and Acronyms Related to Cannabinoids
-
![]()
Sex Differences in Cannabinoid Therapy - Literature Review
Januar - April 2022 Patient-reported outcomes
Patient-Centered Data Collection on the Course of Therapy with Cannabis Medications
In early 2022, Copeia conducted a survey on the course of therapy with cannabis medications, gathering crucial information from the perspective of patients. These data are currently urgently needed for the evaluation and assessment of prescribed cannabis therapies in Germany.
Analysis of the survey results: Published in Springer Medicine, "Der Schmerz"
Featured in
click logos to read more
If you would like to learn more about Copeia or discuss collaboration opportunities, please contact us by email and we will get back to you as soon as possible. We look forward to hearing from you.
Our growing network of partners
Copeia’s founding team brings together proven expertise:
In the German healthcare and pharmacy landscape and in supporting cannabis patients.
Proven track record of delivering AI based tools and workflows to healthcare professionals and development of big data analytics tools that are referenced in high impact health publications.
Collaboration with leading cannabis scientists, clinicians, pharmacists and producers internationally.
If you would like to learn more about Copeia or discuss business opportunities, please contact us by email and we will get back to you as soon as possible. We look forward to hearing from you.
info@copeia.de
